Is oxygen a key factor in the lipodystrophy phenotype?

BACKGROUND: The lipodystrophic syndrome (LD) is a disorder resulting from selective damage of adipose tissue by antiretroviral drugs included in therapy controlling human-immunodeficiency-virus-1. In the therapy cocktail the nucleoside reverse transcriptase inhibitors (NRTI) contribute to the develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentil, Christel, Jan, Sébastien Le, Philippe, Josette, Leibowitch, Jacques, Sonigo, Pierre, Germain, Stéphane, Piétri-Rouxel, France
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1624831/
https://www.ncbi.nlm.nih.gov/pubmed/17049073
http://dx.doi.org/10.1186/1476-511X-5-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1624831/
https://www.ncbi.nlm.nih.gov/pubmed/17049073
http://dx.doi.org/10.1186/1476-511X-5-27

Ejemplares similares